Ultra-Deep Targeted Sequencing Does Not Identify MM Patients with Different Prognosis: Results from a Randomized Phase II Clinical Trial

被引：0
|
作者：
Ruiz-Heredia, Yanira
Martinez-Lopez, Joaquin
Martinez-Avila, Jose Carlos
Sanchez-Vega, Beatriz
Rapado, Inmaculada
Jimenez, Cristina
Braggio, Esteban
Martinez, Rafael
Rosinol, Laura
Ocio, Enrique M.
Echeveste, M. Asuncion
de Oteyza, Jaime Perez
Oriol, Albert
Bargay, Joan
Gironella, Mercedes
Martin, Jesus
Ayala, Rosa M.
Blade, Joan
Stewart, Keith
Mateos, Maria-Victoria
Miguel, Jesus San
Garcia-Sanz, Ramon
Lahuerta, Juan Jose
Aguirre, Xabier
机构：
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2078.2078
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2078
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Impaired Stem Cell Mobilization by Fludarabine in MM: Results from a Randomized Phase II Trial
    Johnsen, H. E.
    Lennhoff, S.
    Tangen
    Gluud, C.
    Knudsen, L. M.
    Mylin, A. K.
    Gimsing, P.
    Gregersen, H.
    Abildgaard, N.
    Nielsen, J. L.
    Andersen, N. F.
    Plesner, T.
    Vangsted, A. J.
    Mourits-Andersen, T.
    Mellqvist, U. H.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S85 - S85
  • [2] AXITINIB FOR THE TREATMENT OF PATIENTS WITH RECURRENT GLIOBLASTOMA, FINAL RESULTS FROM A RANDOMIZED PHASE II CLINICAL TRIAL
    Duerinck, J.
    Du Four, S.
    Bouttens, F.
    Verschaeve, V.
    Andre, C.
    Van Fraeyenhove, F.
    Chaskis, C.
    D'haene, N.
    Salmon, I.
    Neyns, B.
    NEURO-ONCOLOGY, 2016, 18 : 41 - 42
  • [3] Highly multiplexed detection of actionable mutations in surgically resected tumor specimens from Japanese patients with lung adenocarcinoma by ultra-deep targeted sequencing
    Koh, Y.
    Kenmotsu, H.
    Serizawa, M.
    Isaka, M.
    Naito, T.
    Takahashi, T.
    Endo, M.
    Nakajima, T.
    Ohde, Y.
    Yamamoto, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S814 - S814
  • [4] Genomic profiling using targeted ultra-deep next-generation sequencing for prediction of treatment outcome after concurrent chemoradiation: Results from the German ARO-0401 trial.
    Tinhofer, Inge
    Budach, Volker
    Endris, Volker
    Stenzinger, Albrecht
    Weichert, Wilko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] Clinical, virological and immunological characteristics of patients with discordant phenotypic and genotypic (ultra-deep sequencing) tropism test results: analysis of tropism calls in MOTIVATE and 1029
    Chapman, D.
    Valdez, H.
    Lewis, M.
    James, I.
    Heera, J.
    McGovern, R. A.
    Swenson, L. C.
    Harrigan, P. R.
    ANTIVIRAL THERAPY, 2010, 15 : A21 - A21
  • [6] FINAL RESULTS FROM THE AXIG TRIAL: A RANDOMIZED PHASE II CLINICAL TRIAL INVESTIGATING AXITINIB ALONE OR IN COMBINATION WITH CCNU IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Duerinck, Johnny
    Du Four, Stephanie
    Bouttens, Frank
    Verschaeve, Vincent
    Chaskis, Cristo
    Andre, Chantal
    Van Fraeyenhove, Frank
    D'haene, Nicky
    Salmon, Isabelle
    Neyns, Bart
    NEURO-ONCOLOGY, 2016, 18 : 8 - 8
  • [7] Ultra-deep amplicon sequencing to identify actionable mutations in matched plasma/tumor specimens from 44 patients with colorectal cancer of UICC stage III and IV
    Pechanska, Paulina
    Pross, Matthias
    Radke, Cornelia
    Marusch, Frank
    Lobeck, Hartmut
    Bunse, Joerg
    Niedobitek, Gerald
    Mantke, Rene
    Pauli, Roland
    Pertschy, Joerg
    Kosmehl, Hartwig
    Weise, Steffen
    Tennstedt-Schenk, Cornelia
    Hinzmann, Bernd
    Adams, Hans-Peter
    Rosenthal, Andre
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trial
    Reist, Christopher
    Li, Peide
    Nguyen, Thuy Le
    Suessmuth, Sigurd D.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (12):
  • [9] Ultra-deep targeted sequencing to identify HRAS, TP53, and CDKN2A somatic mutations as molecular prognostic markers in patients with advanced oral squamous cell carcinoma.
    Yen, Tzu-Chen
    Peng, Chien-Hua
    Peng, Shih-Chi
    Liao, Chun-Ta
    Hsieh, Wen-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [10] Neovastat (Æ-941), an inhibitor of angiogenesis:: Randomized phase I/II clinical trial results in patients with plaque psoriasis
    Sauder, DN
    DeKoven, J
    Champagne, P
    Croteau, D
    Dupont, E
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (04) : 535 - 541
12345